Back to search results

Pilot Study: Gut-Directed Hypnotherapy for Hospitalized Patients

This study is looking at whether gut-directed hypnotherapy can help hospitalized patients with chronic gastrointestinal (GI) problems like Irritable Bowel Syndrome (IBS) or Inflammatory Bowel Disease (IBD). You might be able to join if you are an adult admitted to Stanford Hospital for worsening pain or nausea related to these conditions. The study will compare self-directed gut-directed hypnotherapy given over the phone to an educational recording about GI symptoms. Researchers want to see how many people join, stick with the intervention, and stay in the study. The study aims to enroll 26 participants and its current status is unclear.

Study design
This is an interventional study comparing two behavioral approaches. It plans to enroll 26 participants.
What's involved
Participants will undergo a self-directed gut-directed hypnosis intervention or listen to an educational recording over the telephone.
Compensation
Not stated in the trial record.
Follow-up
Researchers will measure adherence and retention for up to 3 months, and recruitment for up to 1 year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07676136

A Pilot Study Using Gut-Directed Hypnotherapy for Hospitalized Patients

Not Yet Recruiting
NAAges 18+InterventionalTreatment
Stanford University
~26 participants
Updated 2026-06-30 on ClinicalTrials.gov
What's tested:Gut directed hypnotherapy via telephone interventionEducational recording

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Recruitment rate
Measured over Up to 1 year.
+2 more outcomes measured

Conditions

Disorders of Gut-brain Interaction
Inflammatory Bowel Disease (IBD)
Irritable Bowel Syndrome
Abdominal Pain
Esophageal Disease

Explore related trials

Disorders of Gut-brain InteractionEsophageal DisorderInflammatory Bowel DiseaseIrritable Bowel Syndrome

NCT07676136

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Stanford University

    Stanford, Californiano site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Irene Sonu, MD · PRINCIPAL_INVESTIGATOR · Stanford University

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Adults admitted to the GI inpatient service with expected length of stay \>24 hours
Prior diagnosis of a disorder of gut-brain interaction, esophageal disorder, or inflammatory bowel disease
Reason for hospitalization related to symptom management for exacerbation of visceral pain and/or nausea.

Exclusion

Currently using hypnosis
severe developmental delay or cognitive impairment
serious mental illness (i.e. psychosis or dissociation)
hearing impairment
Non-English speaking
enrolled in another trial for GI symptom management
admitted for GI procedure

What this trial measures

  • Recruitment rateUp to 1 year.

    Recruitment rate is the proportion enrolled among eligible patients approached.

  • Number of participants who adhered to intervention3 months.

    Proportion of participants completing ≥1 hypnosis session during hospitalization and total number of listens

  • Retention rate3 months.

    Retention rate is defined as survey completion at baseline, 1 week, 1 month, and 3 months.